Top Industry Leaders in the Malaria Diagnosis Treatment Market
Latest Africa Malaria Diagnosis and Treatment Companies Update
Abbott receives WHO prequalification for its first-ever fully absorbable tracheal stent, Absorb™, a significant innovation for airway management in severe malaria cases.
Mologic, a Kenyan company, partners with UNICEF to distribute its innovative mosquito repellent patches, Mbuzi Zetu, across Africa, aiming for wider access to preventative measures.
Ghana introduces AI-powered rapid diagnostic tests (RDTs) from Unitaid and FIND, potentially improving accuracy and efficiency in disease detection.
GSK's RTS,S/AS01 (Mosquirix), the world's first malaria vaccine, receives WHO recommendation for broad deployment in children, marking a major milestone in malaria prevention.
Pfizer partners with the Bill & Melinda Gates Foundation to develop and manufacture a next-generation antimalarial drug with the potential for longer-lasting protection.
Medicines for Malaria Venture (MMV) announces $80 million investment in the development of new antimalarial drugs targeting drug-resistant strains.
List of Africa Malaria Diagnosis and Treatment Key Companies in the Market
- Alere Inc.
- Access Bio Inc.
- Premier Medical Corporation
- Beckman Coulter/Danaher
- bioMerieux
- Novartis Diagnostics
- Siemens Healthcare
- Bio-Rad Laboratories
- Cipla Inc.
- Ipca Laboratories Ltd.
- Uni-Med India
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
- Sanofi